Cargando…

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Li, Lifeng, Sun, Shilong, Peng, Mengle, Wu, Kai, Duan, Xiaoran, Xue, Ruyue, Yang, Meijia, Zhang, Xu, Zhao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Journal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585196/ https://www.ncbi.nlm.nih.gov/pubmed/37853949 http://dx.doi.org/10.1002/ctm2.1450

Ejemplares similares

Norepinephrine inhibits CD8(+) T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma
por: Geng, Qishun, et al.
Publicado: (2023)

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021)

6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data
por: Zhang, Xiaoming, et al.
Publicado: (2021)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
por: Zuo, Yanhua, et al.
Publicado: (2023)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

Integrated analysis of EGFR mutated non‐small cell lung cancer reveals two distinct molecular subtypes
por: Bai, Menglin, et al.
Publicado: (2023)

Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma
por: Zhang, Dexin, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning
por: Wang, Qilong, et al.
Publicado: (2023)

Autoimmune encephalitis: frequency and prognosis
por: Al-Ansari, A., et al.
Publicado: (2019)

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
por: Cruz-Rico, Graciela, et al.
Publicado: (2021)

Understanding soft sweeps: a signature of rapid adaptation
por: Garud, Nandita R.
Publicado: (2023)

Metabolomic signatures associated with pathological angiogenesis in moyamoya disease
por: He, Shihao, et al.
Publicado: (2023)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort
por: Zhan, Qian, et al.
Publicado: (2021)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Deep Learning Approach Based on Transcriptome Profile for Data Driven Drug Discovery
por: Kwon, Eun-Ji, et al.
Publicado: (2023)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities
por: Hijazo‐Pechero, Sara, et al.
Publicado: (2023)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
por: Ling, Chen, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

Development and validation of apoptosis‐related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients
por: Hong, Jinjiong, et al.
Publicado: (2022)

Pharmacological Effect of GABA Analogues on GABA-ρ2 Receptors and Their Subtype Selectivity
por: Naffaa, Moawiah M., et al.
Publicado: (2022)

Does Bile Reflux Influence the Progression of Barrett's Esophagus to Adenocarcinoma? (Gastroenterology 2013;145:1300-1311)
por: Masaoka, Tatsuhiro, et al.
Publicado: (2014)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021)

Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus: (Gut 2014;63:1229–1237)
por: Kim, Gwang Ha
Publicado: (2015)

Case Report: Mucinous Adenocarcinoma Arising From Congenital Ejaculatory Duct Cyst
por: Shen, Hua, et al.
Publicado: (2021)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_km9k8798mbdt8vfn8d2f246id4